Atherosclerosis and Hyperlipidemia Research

Atherosclerosis is a disorder of the arteries characterized by the formation of hard structures called atherosclerotic plaques. It is a prevalent disorder, accounting for one third of all deaths in North America.

Atherosclerosis and Hyperlipidemia Research Products Targets

Products for Atherosclerosis and Hyperlipidemia Research - Page 24

Cat.No. Product Name Information/Activity
BCC6862 2-Iminopiperidine hydrochloride 16011-96-4
BCC6837 S-Isopropylisothiourea hydrobromide 4269-97-0
BCC6791 (S)-Methylisothiourea sulfate 867-44-7
BCC5706 L-NIL hydrochloride 150403-89-7
BCC7057 1400W dihydrochloride 1400W dihydrochloride is a potent and selective inhibitor of human inducible NO synthase with Ki values of 7 nM.
BCC7647 ARL 17477 dihydrochloride 866914-87-6
BCC6770 3-Bromo-7-nitroindazole 3-Bromo-7-nitroindazole is a more potent and selective inhibitor of neuronal nitric oxide synthase (nNOS) than eNOS or inducible nitric oxide synthase (iNOS). 3-Bromo-7-nitroindazole affects the intercellular messenger nitric oxide (NO) synthesis throughout the body and brain.
BCC5644 Pentamidine isethionate Pentamidine isethionate (MP-601205 isethionate) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine isethionate inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine isethionate is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine isethionate has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities.
BCC6965 Nω-Propyl-L-arginine hydrochloride 137361-05-8
BCC6762 N-Acetyl-N-acetoxy-4-chlorobenzenesulfonamide 142867-52-5